Xvivo Perfusion AB (publ) (STO:XVIVO)

Market Cap	8.80B
Revenue (ttm)	822.42M
Net Income (ttm)	172.18M
Shares Out	31.50M
EPS (ttm)	5.44
PE Ratio	51.36
Forward PE	61.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,155
Average Volume	235,528
Open	281.40
Previous Close	279.80
Day's Range	276.40 - 282.00
52-Week Range	238.20 - 547.00
Beta	2.08
RSI	34.56
Earnings Date	Apr 24, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 190
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.